Meta Pixel

News and Announcements

Generating stable, high yield with attractive capital return by investing in defensive U.K. Residential Property

  • Published August 13, 2020 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

“With interest rates near zero globally, the investment case for U.K. property, which provides a high, resilient yield (~7%), alongside capital growth, is compelling. And whilst many asset classes appear fully valued at this time, the same cannot be said for this asset class, with house prices in U.K. cities (ex. London) comparatively low, at a median value of 160,000 GBP or ~4x price to household income ratio. Compare this to Sydney at 11x and Melbourne 9x. In addition, we feel the source of both income and capital returns will be uncorrelated to other assets, providing portfolio diversification.”

Kee Gan, Chief Investment Officer

Register Interest

Investment Specialty

L1 Capital has been successfully investing into U.K. residential property since 2017. The Fund’s strategy is focused on investing in existing and fully tenanted modern residential property in major U.K. cities (excluding London) that provide an attractive and reliable income stream with the potential for capital growth.

Unique Investing Methodology

L1 has a team based in London and has been managing the strategy for three years.  The Fund is likely to benefit from being an early investor in the asset class and one of the few managers offering this strategy to high net worth individuals. L1 finds competition for these assets to be limited, as the transaction sizes are typically too small for the institutional investor, and too large for high net worth individuals. The Fund is able to transact at a significant discount to open market values (~20% discount) and rebuild costs (~35%).

Track Record

  • Fund I raised $65 million in equity and is currently yielding in excess of 6% p.a. (net of fees and expenses).
  • Fund II raised $45 million in equity and is currently yielding in excess of 6% p.a. (net of fees and expenses).
  • In addition to yield, Funds I and II have generated attractive capital gains for investors.

Team Experience

Kee Gan, Chief Investment Officer, leads a team of 6 in our London office. Prior to joining L1 in 2017, he spent ten years in investment banking at Deutsche Bank across London, Hong Kong and Australia advising private equity clients.  U.K. real estate transactions include the IPO of Countrywide in 2014 (the U.K.s largest real estate agency). Prior to Deutsche he spent two years at Bain & Co. providing corporate strategy to Australian Blue-chip companies.

The Offer

L1 Capital is looking to raise capital in line with Funds I, II and III.  The minimum investment size is $50,000 AUD.

Notable Achievements

To date, fully invested Funds I and II are exceeding their income and growth return targets.

Register Interest

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now